519 related articles for article (PubMed ID: 24335555)
21. Clostridium difficile and the microbiota.
Seekatz AM; Young VB
J Clin Invest; 2014 Oct; 124(10):4182-9. PubMed ID: 25036699
[TBL] [Abstract][Full Text] [Related]
22. [Side effects of antibiotic: diarrhea and Clostridium difficile infection.].
Capurso L; Koch M
Recenti Prog Med; 2021 Jan; 112(1):4-26. PubMed ID: 33576348
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.
Rousseau C; Levenez F; Fouqueray C; Doré J; Collignon A; Lepage P
J Clin Microbiol; 2011 Mar; 49(3):858-65. PubMed ID: 21177896
[TBL] [Abstract][Full Text] [Related]
24. Bile salt metabolism is not the only factor contributing to
Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
[TBL] [Abstract][Full Text] [Related]
25. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
26. Food for thought-The link between Clostridioides difficile metabolism and pathogenesis.
Marshall A; McGrath JW; Graham R; McMullan G
PLoS Pathog; 2023 Jan; 19(1):e1011034. PubMed ID: 36602960
[TBL] [Abstract][Full Text] [Related]
27. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection.
Bassis CM; Theriot CM; Young VB
Antimicrob Agents Chemother; 2014 May; 58(5):2767-74. PubMed ID: 24590475
[TBL] [Abstract][Full Text] [Related]
28. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
Winston JA; Theriot CM
Anaerobe; 2016 Oct; 41():44-50. PubMed ID: 27163871
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.
Stiefel U; Nerandzic MM; Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4535-42. PubMed ID: 24867962
[TBL] [Abstract][Full Text] [Related]
30. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
[No Abstract] [Full Text] [Related]
31. The Stickland Reaction Precursor
Reed AD; Fletcher JR; Huang YY; Thanissery R; Rivera AJ; Parsons RJ; Stewart AK; Kountz DJ; Shen A; Balskus EP; Theriot CM
mSphere; 2022 Apr; 7(2):e0092621. PubMed ID: 35350846
[TBL] [Abstract][Full Text] [Related]
32. An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile.
Miezeiewski M; Schnaufer T; Muravsky M; Wang S; Caro-Aguilar I; Secore S; Thiriot DS; Hsu C; Rogers I; DeSantis T; Kuczynski J; Probst AJ; Chehoud C; Steger R; Warrington J; Bodmer JL; Heinrichs JH
ISME J; 2015 Feb; 9(2):321-32. PubMed ID: 25036923
[TBL] [Abstract][Full Text] [Related]
33. Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.
Steinway SN; Biggs MB; Loughran TP; Papin JA; Albert R
PLoS Comput Biol; 2015 May; 11(5):e1004338. PubMed ID: 26102287
[TBL] [Abstract][Full Text] [Related]
34. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract.
Koenigsknecht MJ; Theriot CM; Bergin IL; Schumacher CA; Schloss PD; Young VB
Infect Immun; 2015 Mar; 83(3):934-41. PubMed ID: 25534943
[TBL] [Abstract][Full Text] [Related]
35. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
[TBL] [Abstract][Full Text] [Related]
36. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
[TBL] [Abstract][Full Text] [Related]
37. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
[TBL] [Abstract][Full Text] [Related]
38. New perspectives in Clostridium difficile disease pathogenesis.
Monaghan TM
Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
[TBL] [Abstract][Full Text] [Related]
39. Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant.
Leslie JL; Jenior ML; Vendrov KC; Standke AK; Barron MR; O'Brien TJ; Unverdorben L; Thaprawat P; Bergin IL; Schloss PD; Young VB
mBio; 2021 Mar; 12(2):. PubMed ID: 33785619
[No Abstract] [Full Text] [Related]
40. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
